Vilin Bio-Med was incorporated on June 29, 2005. The company is engaged in the domestic business of manufacturing pharmaceutical products, and its manufacturing unit is located in Roorkee, Uttarakhand. The company sells its products in bulk to pharmaceutical manufacturers, marketers, and traders, who then provide the channel for sales to customers.
| Bidding Dates |
|---|
| 16 Jun 2023 - 21 Jun 2023 |
| Subscription |
|---|
| 2.7x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,20,000 | 1 | 1 | 4000 | 4.0 M | ₹30 | 71.33 % | ₹120.0 M | RHP DOC |
Vilin Bio Med IPO SUBSCRIPTION STATUS
21 Jun '23Vilin Bio Med IPO overall subscription rate was 2.7 times the total available shares
Vilin Bio Med IPO retail subscription rate was 4.09 times in the retail segment
Vilin Bio Med IPO non-institutional investor subscription rate was 1.32 times in the non-institutional investor category
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 50% | 50% | - |
21 Jun 2023 (Day 4) | 4.09x | 1.32x | - |
20 Jun 2023 (Day 3) | 2.23x | 0.12x | - |
19 Jun 2023 (Day 2) | 1.2x | 0.05x | - |
16 Jun 2023 (Day 1) | 0.53x | 0.01x | - |
Vilin Bio Med FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) | Margins |
| 9MFY23 | 12.8 | 90.1 | 65.1 | 64.9 | 26.1% |
| FY22 | 0.3 | 112.1 | 2.1 | 2.1 | 6.9% |
| FY21 | 1.2 | 117.2 | -10.0 | -10.0 | 7.3% |
| FY20 | 1.6 | 168.1 | -14.6 | -14.8 | 5.4% |
Vilin Bio Med IPO SUBSCRIPTION STATUS DETAILS
Vilin Bio Med had 4.0 M shares on offer
Vilin Bio Med IPO offer price was ₹30
Vilin Bio Med IPO minimum Investment was ₹120000
Vilin Bio Med IPO issue size was ₹ 120.0 M
Vilin Bio Med had a minimum lot size of 4000 Shares per application
Vilin Bio Med NUMBER OF SHARES ON OFFER
Vilin Bio Med IPO IMPORTANT DATES
| Issue Open Date | 16 Jun 2023 |
| Issue close Date | 21 Jun 2023 |
| Allotment Date | 26 Jun 2023 |
| Refund Date | 27 Jun 2023 |
| Demat Account Credit Date | 29 Jun 2023 |
| Listing Date | 30 Jun 2023 |
| Listing on Exchange(s) | NSE |
| Vilin Bio Med Allotment Status | Exchange |
Vilin Bio Med IPO subscription opened on 16 Jun 2023, and closed on 21 Jun 2023
IPO allotment for Vilin Bio Med was finalized on Monday, 26 Jun 2023
IPO listing for Vilin Bio Med was on NSE on Friday, 30 Jun 2023
Vilin Bio Med IPO LISTING GAINS
| Issue Price (adjusted) | 30.0 |
| Listing Open Price | 30.0 |
| Listing Close Price | 28.5 |
| Listing Gain% | 0.0% |
| Current Gain% | 46.8% |
Vilin Bio Med Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vilin Bio Med Ltd. | 44 | 61.4 | 34.8 | 0.1 | 1.5 | 6.8 | 5.5 | 42.3 | 176.6 | 1.9 | 763 | 1.3 | 689.4 |
| Sun Pharmaceutical Industries Ltd. | 1945 | 466670.7 | 38.6 | 2.3 | 7.8 | 13.7 | 10.6 | 60433.8 | 10.8 | 11479.4 | 5 | 50.4 | 16.6 |
| Divi's Laboratories Ltd. | 8275 | 219675.3 | 75.1 | 2.8 | 19.6 | 15.3 | 12.8 | 11067 | 14 | 2568 | 17.2 | 110.2 | 26.8 |
| Torrent Pharmaceuticals Ltd. | 4924 | 187293.2 | 85.9 | 9.6 | 11.9 | 25.8 | 4.9 | 13886.2 | 20.3 | 2163.4 | 13.2 | 57.3 | 8.9 |
| Cipla Ltd. | 1463.8 | 118253.6 | 35.1 | -0.9 | 4.2 | 11.3 | 9.1 | 29044.6 | 2.2 | 3879.2 | -26.4 | 41.7 | -37.5 |
| Zydus Lifesciences Ltd. | 1114.2 | 112114.6 | 22.2 | 2.3 | 4.1 | 18.6 | 9.6 | 27657.9 | 17.6 | 5040 | 11.4 | 50.1 | 9.6 |
Vilin Bio Med INFORMATION ON IPO ISSUE
About Vilin Bio Med
Vilin Bio-Med was incorporated on June 29, 2005. The company is engaged in the domestic business of manufacturing pharmaceutical products, and its manufacturing unit is located in Roorkee, Uttarakhand. The company sells its products in bulk to pharmaceutical manufacturers, marketers, and traders, who then provide the channel for sales to customers.
Object of the Issue
- Augmenting additional working capital requirements
- General corporate purposes
Vilin Bio Med - PROMOTERS
| Name |
|---|
| Viswa Prasad Sadhanala |
| Ramesh Reddy Sama |
| Sadhanala Venkata Rao |
| D. Srinivasa Reddy |
Vilin Bio Med Lead Manager
Inventure Merchant Banker Services Private Limited
compliance@inventuremerchantbanker.com
Vilin Bio Med Registrar to the issue
Bigshare Services Private Limited
ipo@bigshareonline.com
Vilin Bio Med Strengths
Quality assurance
The company has an in-house testing laboratory within its manufacturing unit to test the products. The finished products undergo quality checks to ensure compliance with both domestic and international quality standards
Experienced management
The management team possesses the necessary expertise in the pharmaceutical manufacturing sector to effectively address operational issues, develop business strategies, and navigate market challenges
Vilin Bio Med Risks
Outstanding legal proceedings
There are pending legal proceedings against the company that have the potential to negatively impact its business, financial condition, and operating results
Dependent on few customers
The company has historically relied on, and may continue to rely on, a significant portion of its income from its top 10 customers
IPO FAQs
The promoters of the company are Viswa Prasad Sadhanala, Ramesh Reddy Sama, Sadhanala Venkata Rao and D. Srinivasa Reddy.
The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.
The price band of the IPO is Rs 30.0 - 30.0.
The IPO application opens on Jun 16, 2023 and closes on Jun 21, 2023.
The minimum lot size for the IPO is 4000. The maximum lot size for the IPO is 4000.
For all category investors, the minimum application amount for this IPO is Rs. 120,000.0, the maximum value for this IPO is Rs 120,000.0.
This IPO will be allotted on Jun 26, 2023.
The refund will be credited to your account on Jun 27, 2023.
The allotted shares will be credited to your demat on Jun 29, 2023.
Vilin Bio Med Ltd.’s shares listed on the stock exchanges on Jun 30, 2023.